About Fractyl Health
Addressing root causes of metabolic disease—in the gut
Fractyl Health is an organ editing metabolic therapeutics company pioneering a new approach to the treatment of type 2 diabetes (T2D). Our goal is to transform treatment from chronic blood glucose management to disease-modifying therapies that target the organ-level root causes of T2D.
We have assembled a mission-driven team of innovators, united in a passion to eradicate T2D and to develop breakthrough therapies—the type of therapies we would want for ourselves, our family members, and our loved ones with the disease.
Our approach involves identifying diseased metabolic organs at the root of the T2D disease process and designing disease-modifying treatments that aim to reverse the core pathology in these organs that is driving the disease process. We believe that addressing the diseased organs in a manner that is designed to restore their metabolic health and function offers the potential for disease eradication in a manner that current approaches, focused on lifestyle intervention or pharmacological management, have not been able to achieve. We call this approach “organ editing.”
We are experts in metabolic disease.